Essa Pharma Inc (EPIX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Dr. David Ross Parkinson
Employees:
SUITE 720, 999 WEST BROADWAY, VANCOUVER, CANADA V5Z 1K5
(778) 331-0962

ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

Data derived from most recent annual or quarterly report
Market Cap 279.922 Million Shares Outstanding32.064 Million Avg 30-day Volume 149.602 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.93
Price to Revenue0.0 Debt to Equity0.0 EBITDA-24.183 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value0
Current Ratio66.729 EPS Growth0 Quick Ratio65.354
1 Yr BETA 1.1837 52-week High/Low 36.0 / 7.42 Profit Margin0.0
Operating Cash Flow Growth-38.6387 Altman Z-Score0.0 Free Cash Flow to Firm -18.008 Million
View SEC Filings from EPIX instead.

View recent insider trading info

Funds Holding EPIX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EPIX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BIOTECH GROWTH N V

BB BIOTECH AG

  • 10% Owner
5,015,814 2021-08-18 2

BERGER FRANKLIN M

  • Director
957,244 2021-02-22 1

ZWEIFACH SANFORD S

  • Director
0 2020-12-11 0

GLICKMAN RICHARD M

  • Director
0 2020-12-11 0

PARKINSON DAVID ROSS CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-12-11 0

MARTIN JOHN ALEXANDER

  • Director
0 2020-12-11 0

REQUADT SCOTT

  • Director
0 2020-12-11 0

BRETTMAN ARI DAVID

  • Director
0 2020-12-11 0

VIRSIK PETER CHIEF OPERATING OFFICER

  • Officer
0 2020-12-11 0

THORELL MARELLA

  • Director
0 2020-12-11 0

SOLLIS GARY

  • Director
0 2020-12-11 0

WOOD DAVID S. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-12-11 0

CESANO ALESSANDRA CHIEF MEDICAL OFFICER

  • Officer
0 2020-12-11 0

CLARUS LIFESCIENCES III, L.P.

CLARUS VENTURES III GP, L.P.

BLACKSTONE CLARUS III L.L.C.

BLACKSTONE HOLDINGS II L.P.

BLACKSTONE HOLDINGS I/II GP L.L.C.

BLACKSTONE GROUP INC

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
3,573,053 2020-10-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ESSA PHARMA INC EPIX 2022-01-19 16:45:03 UTC -0.3307 0.4007 10000
ESSA PHARMA INC EPIX 2022-01-19 16:15:03 UTC -0.3307 0.4007 10000
ESSA PHARMA INC EPIX 2022-01-19 15:45:03 UTC -0.3307 0.4007 10000
ESSA PHARMA INC EPIX 2022-01-19 15:15:03 UTC -0.3307 0.4007 10000
ESSA PHARMA INC EPIX 2022-01-19 14:45:03 UTC -0.3117 0.3817 10000
ESSA PHARMA INC EPIX 2022-01-19 14:15:03 UTC -0.3117 0.3817 10000
ESSA PHARMA INC EPIX 2022-01-19 13:45:03 UTC -0.3117 0.3817 10000
ESSA PHARMA INC EPIX 2022-01-19 13:15:03 UTC -0.3117 0.3817 10000
ESSA PHARMA INC EPIX 2022-01-19 12:45:03 UTC -0.3117 0.3817 10000
ESSA PHARMA INC EPIX 2022-01-18 22:15:03 UTC -0.3117 0.3817 25000
ESSA PHARMA INC EPIX 2022-01-18 21:45:04 UTC -0.3117 0.3817 25000
ESSA PHARMA INC EPIX 2022-01-18 21:15:03 UTC -0.3117 0.3817 25000
ESSA PHARMA INC EPIX 2022-01-18 20:45:04 UTC -0.3117 0.3817 25000
ESSA PHARMA INC EPIX 2022-01-18 20:15:05 UTC -0.3117 0.3817 25000
ESSA PHARMA INC EPIX 2022-01-18 19:45:03 UTC -0.3117 0.3817 25000
ESSA PHARMA INC EPIX 2022-01-18 19:15:03 UTC -0.3117 0.3817 25000
ESSA PHARMA INC EPIX 2022-01-18 18:45:03 UTC -0.3117 0.3817 25000
ESSA PHARMA INC EPIX 2022-01-18 18:15:04 UTC -0.3117 0.3817 25000
ESSA PHARMA INC EPIX 2022-01-18 17:45:03 UTC -0.3117 0.3817 25000
ESSA PHARMA INC EPIX 2022-01-18 17:15:03 UTC -0.3117 0.3817 25000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments